ARK Investment Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $98.4M | Sell |
3,053,818
-833,729
| -21% | -$30.9M | 0.76% | 38 |
|
|
2025
Q4 | $164M | Sell |
3,887,547
-578,228
| -13% | -$23.3M | 1.09% | 30 |
|
|
2025
Q3 | $153M | Buy |
4,465,775
+665,686
| +18% | +$19.1M | 0.91% | 30 |
|
|
2025
Q2 | $103M | Sell |
3,800,089
-139,213
| -4% | -$4.03M | 0.75% | 37 |
|
|
2025
Q1 | $117M | Sell |
3,939,302
-264,649
| -6% | -$10.1M | 1.17% | 25 |
|
|
2024
Q4 | $166M | Sell |
4,203,951
-716,794
| -15% | -$27.1M | 1.39% | 22 |
|
|
2024
Q3 | $168M | Sell |
4,920,745
-1,888,552
| -28% | -$53.1M | 1.53% | 20 |
|
|
2024
Q2 | $148M | Sell |
6,809,297
-233,486
| -3% | -$4.91M | 1.31% | 25 |
|
|
2024
Q1 | $156M | Sell |
7,042,783
-612,820
| -8% | -$15M | 1.08% | 28 |
|
|
2023
Q4 | $211M | Buy |
7,655,603
+62,011
| +0.8% | +$1.5M | 1.25% | 23 |
|
|
2023
Q3 | $170M | Sell |
7,593,592
-234,700
| -3% | -$6.04M | 1.3% | 21 |
|
|
2023
Q2 | $199M | Sell |
7,828,292
-580,814
| -7% | -$14.1M | 1.32% | 21 |
|
|
2023
Q1 | $188M | Buy |
8,409,106
+108,865
| +1% | +$2.63M | 1.29% | 22 |
|
|
2022
Q4 | $197M | Sell |
8,300,241
-781,122
| -9% | -$18.2M | 1.71% | 21 |
|
|
2022
Q3 | $151M | Buy |
9,081,363
+225,118
| +3% | +$5.07M | 1.05% | 25 |
|
|
2022
Q2 | $156M | Buy |
8,856,245
+100,221
| +1% | +$2.02M | 0.92% | 28 |
|
|
2022
Q1 | $241M | Buy |
8,756,024
+533,743
| +6% | +$15.3M | 1.01% | 27 |
|
|
2021
Q4 | $339M | Buy |
8,222,281
+1,242,080
| +18% | +$54.9M | 1.02% | 30 |
|
|
2021
Q3 | $324M | Buy |
6,980,201
+290,938
| +4% | +$12.7M | 0.78% | 31 |
|
|
2021
Q2 | $267M | Sell |
6,689,263
-928,024
| -12% | -$39.7M | 0.5% | 52 |
|
|
2021
Q1 | $409M | Sell |
7,617,287
-1,410,540
| -16% | -$81.2M | 0.81% | 36 |
|
|
2020
Q4 | $442M | Buy |
9,027,827
+2,009,057
| +29% | +$93.1M | 1.18% | 29 |
|
|
2020
Q3 | $228M | Buy |
7,018,770
+1,954,977
| +39% | +$62.1M | 1.35% | 24 |
|
|
2020
Q2 | $131M | Buy |
5,063,793
+1,797,934
| +55% | +$44.8M | 1.41% | 23 |
|
|
2020
Q1 | $79.4M | Buy |
3,265,859
+477,423
| +17% | +$12M | 1.98% | 17 |
|
|
2019
Q4 | $77.9M | Buy |
2,788,436
+205,638
| +8% | +$5.32M | 1.96% | 18 |
|
|
2019
Q3 | $62M | Sell |
2,582,798
-453,855
| -15% | -$12.1M | 1.35% | 25 |
|
|
2019
Q2 | $86.6M | Sell |
3,036,653
-422,420
| -12% | -$10.6M | 2.18% | 13 |
|
|
2019
Q1 | $86.5M | Sell |
3,459,073
-34,182
| -1% | -$653K | 2.47% | 12 |
|
|
2018
Q4 | $43.9M | Sell |
3,493,255
-447,549
| -11% | -$5.29M | 1.78% | 24 |
|
|
2018
Q3 | $37.6M | Buy |
3,940,804
+180,145
| +5% | +$1.99M | 1.14% | 33 |
|
|
2018
Q2 | $35.1M | Buy |
3,760,659
+949,365
| +34% | +$6.68M | 1.29% | 28 |
|
|
2018
Q1 | $15.6M | Buy |
2,811,294
+1,409,030
| +100% | +$8.72M | 0.78% | 43 |
|
|
2017
Q4 | $9.16M | Buy |
1,402,264
+913,926
| +187% | +$6.79M | 0.73% | 46 |
|
|
2017
Q3 | $4.28M | Buy |
488,338
+325,318
| +200% | +$2.65M | 0.52% | 53 |
|
|
2017
Q2 | $1.36M | Buy |
163,020
+103,157
| +172% | +$841K | 0.26% | 55 |
|
|
2017
Q1 | $550K | Buy |
59,863
+14,512
| +32% | +$119K | 0.16% | 60 |
|
|
2016
Q4 | $351K | Buy |
+45,351
| New | +$339K | 0.13% | 62 |
|
Other funds holding VCYT
VPM
VCM
ARK Investment Management's VCYT Position: Q1 2026 in Review
ARK Investment Management reduced its Veracyte (VCYT) stake by 21% in Q1 2026, selling an estimated $30.9M and leaving 3,053,818 shares worth $98.4M. The position accounts for 0.76% of the portfolio, ranked #38.
ARK Investment Management first reported a position in VCYT in Q4 2016 and has held it in 38 quarters since. The position peaked at $442M in Q4 2020. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- ARK Investment Management held 3,053,818 shares of Veracyte worth $98.4M as of Q1 2026.
- ARK Investment Management sold 833,729 Veracyte shares in Q1 2026, an estimated $30.9M.
- Veracyte made up 0.76% of ARK Investment Management's portfolio in Q1 2026, its #38 holding.
- ARK Investment Management first reported a position in Veracyte in Q4 2016 and has held it in 38 quarters since.
- ARK Investment Management's Veracyte position peaked at $442M in Q4 2020.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on ARK Investment Management's 13F filing for Q1 2026, filed 12 May 2026.